We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

FAPON

Fapon is a global IVD raw materials & one-stop solutions company offering 700+ reagent raw materials for the applicat... read more Featured Products: More products

Download Mobile App





Fapon Introduces One-Stop Chemiluminescence Immunoassay Solution at MEDICA 2022

By LabMedica International staff writers
Posted on 14 Nov 2022
Print article
Image: Fapon is displaying its extensive IVD product portfolio at MEDICA 2022 (Photo courtesy of Fapon)
Image: Fapon is displaying its extensive IVD product portfolio at MEDICA 2022 (Photo courtesy of Fapon)

Fapon Biotech Inc. (Dongguan, China) is displaying its extensive IVD product portfolio at MEDICA 2022 comprising of core IVD raw materials for immunoassays and molecular diagnostics, including 1300+ antibodies, antigens, enzymes, blockers, etc.; reagent services for comprehensive disease testing; open instrument platforms for chemiluminescence Immunoassay (CLIA) and molecular diagnostics; and its one-stop solution for CLIA.

At this year’s edition of MEDICA, Fapon is exhibiting the Shine i1000 fully automatic and simple-to-use benchtop CLIA analyzer which has a throughput of 120 tests per hour and provides the first result in less than 15 minutes. Shine i1000 combines incubation, washing and detection in an all-in-one innovative design and its small size with a weight of less than 38 kg makes it ideal for different settings. Fapon is also displaying the Shine i2000 fully automatic CLIA analyzer which has a throughput of up to 200 tests per hour and takes 10-15 minutes to deliver the first result. Shine i2000 has a built-in 10-12 point calibration curve with 2-3 point verification and offers convenience with a three hour walk away capacity.

Alongside the CLIA analyzers, Fapon’s rapid molecular diagnostic systems, the P810 and iCatch 2000, are also on display at MEDICA 2022. The P810 is a real-time fluorescence quantitative PCR analyzer that is designed for scientific research and medical applications which integrates nucleic acid amplification, result analysis and report delivery. iCatch 2000 is a fully automatic nucleic acid analyzer which can realize sample-to-answer automation within 30 minutes. In addition, is highlighting its raw materials and reagent solutions for both immunoassay and molecular diagnostics platforms, such as cardiac markers, tumor markers, respiratory disease, inflammatory markers, tropical diseases, infectious diseases, drug of abuse, polymerase & mix, reverse transcriptase & mix, LAMP polymerase, etc.

Related Links:
Fapon Biotech Inc

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Researchers have found a way to spot the debilitating disease Alzheimer\'s before it develops into dementia (Photo courtesy of 123RF)

Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia

Alzheimer’s disease is well known for its slow development over many years, which typically leads to treatment interventions only after the disease has advanced to stages where it may be nearly impossible... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.